Visual recovery after radiation therapy for bilateral subfoveal acute myelogenous leukemia (AML)
Present a case of bilateral foveal acute myelogenous leukemic tumors that responded to radiation therapy. Case report. A patient was diagnosed with bilateral subfoveal infiltration of known systemic acute myelogenous leukemia. He received a standard induction chemotherapy, followed by consolidation...
Gespeichert in:
Veröffentlicht in: | American journal of ophthalmology 2004-10, Vol.138 (4), p.659-662 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 662 |
---|---|
container_issue | 4 |
container_start_page | 659 |
container_title | American journal of ophthalmology |
container_volume | 138 |
creator | Finger, Paul T. Pro, Michael J. Schneider, Susan Kurli, Madhavi Shapira, Ilan Hu, Kenneth |
description | Present a case of bilateral foveal acute myelogenous leukemic tumors that responded to radiation therapy.
Case report.
A patient was diagnosed with bilateral subfoveal infiltration of known systemic acute myelogenous leukemia. He received a standard induction chemotherapy, followed by consolidation therapy for his systemic leukemia. However, despite a complete marrow response, the intraocular tumors did not regress. Therefore, he was given low dose (1950-cGy) ocular external beam radiation therapy.
One course of systemic cytarabine chemotherapy failed to control the subfoveal tumors, leaving the patient at risk for permanent vision loss. In contrast, external beam radiation therapy improved his vision from 20/60 in his right eye to 20/20 and from 20/70 in his left eye to 20/25.
Although systemic chemotherapy can be used to treat intraocular metastasis, external beam radiation may provide more prompt resolution of vision-threatening tumors. |
doi_str_mv | 10.1016/j.ajo.2004.04.047 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66975669</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002939404004611</els_id><sourcerecordid>3556265351</sourcerecordid><originalsourceid>FETCH-LOGICAL-c407t-3a31dc30d2d8443c06b6c38cb6a3d02c8a48540c0a4d37afe482999b4389be783</originalsourceid><addsrcrecordid>eNp9kU2LFDEQQIMo7jj6A7xIQBQ99Jh0MvnA07LoujCLF_Uaq9PVmra7MybdC_Pvze4MLOxBUqQS8qooXgh5ydmGM64-9Bvo46ZmTG7uQj8iK260rbix_DFZMcbqygorz8iznPtyVVrqp-SMb6UxhtUr8vNHyAsMNKGPN5gOFLoZE03QBphDnOj8GxPsD7SLiTZhgPJa8Lw0XeHLCfwyIx0POMRfOMUl0wGXPzgGoO_Or3fvn5MnHQwZX5zymnz__OnbxZdq9_Xy6uJ8V3nJ9FwJELz1grV1a6QUnqlGeWF8o0C0rPYGpNlK5hnIVmjoUJraWttIYWyD2og1eXvsu0_x74J5dmPIHocBJixTOaWs3patgK8fgH1c0lRmc1zJ4kWwstaEHymfYs4JO7dPYYR0cJy5W_mud0W-u5Xv7kKXmlenzkszYntfcbJdgDcnALKHoUsw-ZDvOVVzbpUq3Mcjh0XYTcDksg84eWxD-afZtTH8Z4x_Pm-hZw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1644883030</pqid></control><display><type>article</type><title>Visual recovery after radiation therapy for bilateral subfoveal acute myelogenous leukemia (AML)</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Finger, Paul T. ; Pro, Michael J. ; Schneider, Susan ; Kurli, Madhavi ; Shapira, Ilan ; Hu, Kenneth</creator><creatorcontrib>Finger, Paul T. ; Pro, Michael J. ; Schneider, Susan ; Kurli, Madhavi ; Shapira, Ilan ; Hu, Kenneth</creatorcontrib><description>Present a case of bilateral foveal acute myelogenous leukemic tumors that responded to radiation therapy.
Case report.
A patient was diagnosed with bilateral subfoveal infiltration of known systemic acute myelogenous leukemia. He received a standard induction chemotherapy, followed by consolidation therapy for his systemic leukemia. However, despite a complete marrow response, the intraocular tumors did not regress. Therefore, he was given low dose (1950-cGy) ocular external beam radiation therapy.
One course of systemic cytarabine chemotherapy failed to control the subfoveal tumors, leaving the patient at risk for permanent vision loss. In contrast, external beam radiation therapy improved his vision from 20/60 in his right eye to 20/20 and from 20/70 in his left eye to 20/25.
Although systemic chemotherapy can be used to treat intraocular metastasis, external beam radiation may provide more prompt resolution of vision-threatening tumors.</description><identifier>ISSN: 0002-9394</identifier><identifier>EISSN: 1879-1891</identifier><identifier>DOI: 10.1016/j.ajo.2004.04.047</identifier><identifier>PMID: 15488802</identifier><identifier>CODEN: AJOPAA</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adult ; Biological and medical sciences ; Bone marrow ; Chemotherapy ; Diseases of the eye ; Fluorescein Angiography ; Hematologic and hematopoietic diseases ; Humans ; Leukemia ; Leukemia, Myeloid, Acute - physiopathology ; Leukemia, Myeloid, Acute - radiotherapy ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Male ; Medical sciences ; Radiation therapy ; Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) ; Recovery of Function - physiology ; Retinal Neoplasms - physiopathology ; Retinal Neoplasms - radiotherapy ; Tumors ; Visual Acuity - physiology</subject><ispartof>American journal of ophthalmology, 2004-10, Vol.138 (4), p.659-662</ispartof><rights>2004 Elsevier Inc.</rights><rights>2004 INIST-CNRS</rights><rights>Copyright Elsevier Limited Oct 2004</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c407t-3a31dc30d2d8443c06b6c38cb6a3d02c8a48540c0a4d37afe482999b4389be783</citedby><cites>FETCH-LOGICAL-c407t-3a31dc30d2d8443c06b6c38cb6a3d02c8a48540c0a4d37afe482999b4389be783</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ajo.2004.04.047$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16211966$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15488802$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Finger, Paul T.</creatorcontrib><creatorcontrib>Pro, Michael J.</creatorcontrib><creatorcontrib>Schneider, Susan</creatorcontrib><creatorcontrib>Kurli, Madhavi</creatorcontrib><creatorcontrib>Shapira, Ilan</creatorcontrib><creatorcontrib>Hu, Kenneth</creatorcontrib><title>Visual recovery after radiation therapy for bilateral subfoveal acute myelogenous leukemia (AML)</title><title>American journal of ophthalmology</title><addtitle>Am J Ophthalmol</addtitle><description>Present a case of bilateral foveal acute myelogenous leukemic tumors that responded to radiation therapy.
Case report.
A patient was diagnosed with bilateral subfoveal infiltration of known systemic acute myelogenous leukemia. He received a standard induction chemotherapy, followed by consolidation therapy for his systemic leukemia. However, despite a complete marrow response, the intraocular tumors did not regress. Therefore, he was given low dose (1950-cGy) ocular external beam radiation therapy.
One course of systemic cytarabine chemotherapy failed to control the subfoveal tumors, leaving the patient at risk for permanent vision loss. In contrast, external beam radiation therapy improved his vision from 20/60 in his right eye to 20/20 and from 20/70 in his left eye to 20/25.
Although systemic chemotherapy can be used to treat intraocular metastasis, external beam radiation may provide more prompt resolution of vision-threatening tumors.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Bone marrow</subject><subject>Chemotherapy</subject><subject>Diseases of the eye</subject><subject>Fluorescein Angiography</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Humans</subject><subject>Leukemia</subject><subject>Leukemia, Myeloid, Acute - physiopathology</subject><subject>Leukemia, Myeloid, Acute - radiotherapy</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Radiation therapy</subject><subject>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</subject><subject>Recovery of Function - physiology</subject><subject>Retinal Neoplasms - physiopathology</subject><subject>Retinal Neoplasms - radiotherapy</subject><subject>Tumors</subject><subject>Visual Acuity - physiology</subject><issn>0002-9394</issn><issn>1879-1891</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU2LFDEQQIMo7jj6A7xIQBQ99Jh0MvnA07LoujCLF_Uaq9PVmra7MybdC_Pvze4MLOxBUqQS8qooXgh5ydmGM64-9Bvo46ZmTG7uQj8iK260rbix_DFZMcbqygorz8iznPtyVVrqp-SMb6UxhtUr8vNHyAsMNKGPN5gOFLoZE03QBphDnOj8GxPsD7SLiTZhgPJa8Lw0XeHLCfwyIx0POMRfOMUl0wGXPzgGoO_Or3fvn5MnHQwZX5zymnz__OnbxZdq9_Xy6uJ8V3nJ9FwJELz1grV1a6QUnqlGeWF8o0C0rPYGpNlK5hnIVmjoUJraWttIYWyD2og1eXvsu0_x74J5dmPIHocBJixTOaWs3patgK8fgH1c0lRmc1zJ4kWwstaEHymfYs4JO7dPYYR0cJy5W_mud0W-u5Xv7kKXmlenzkszYntfcbJdgDcnALKHoUsw-ZDvOVVzbpUq3Mcjh0XYTcDksg84eWxD-afZtTH8Z4x_Pm-hZw</recordid><startdate>20041001</startdate><enddate>20041001</enddate><creator>Finger, Paul T.</creator><creator>Pro, Michael J.</creator><creator>Schneider, Susan</creator><creator>Kurli, Madhavi</creator><creator>Shapira, Ilan</creator><creator>Hu, Kenneth</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20041001</creationdate><title>Visual recovery after radiation therapy for bilateral subfoveal acute myelogenous leukemia (AML)</title><author>Finger, Paul T. ; Pro, Michael J. ; Schneider, Susan ; Kurli, Madhavi ; Shapira, Ilan ; Hu, Kenneth</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c407t-3a31dc30d2d8443c06b6c38cb6a3d02c8a48540c0a4d37afe482999b4389be783</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Bone marrow</topic><topic>Chemotherapy</topic><topic>Diseases of the eye</topic><topic>Fluorescein Angiography</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Humans</topic><topic>Leukemia</topic><topic>Leukemia, Myeloid, Acute - physiopathology</topic><topic>Leukemia, Myeloid, Acute - radiotherapy</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Radiation therapy</topic><topic>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</topic><topic>Recovery of Function - physiology</topic><topic>Retinal Neoplasms - physiopathology</topic><topic>Retinal Neoplasms - radiotherapy</topic><topic>Tumors</topic><topic>Visual Acuity - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Finger, Paul T.</creatorcontrib><creatorcontrib>Pro, Michael J.</creatorcontrib><creatorcontrib>Schneider, Susan</creatorcontrib><creatorcontrib>Kurli, Madhavi</creatorcontrib><creatorcontrib>Shapira, Ilan</creatorcontrib><creatorcontrib>Hu, Kenneth</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Finger, Paul T.</au><au>Pro, Michael J.</au><au>Schneider, Susan</au><au>Kurli, Madhavi</au><au>Shapira, Ilan</au><au>Hu, Kenneth</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Visual recovery after radiation therapy for bilateral subfoveal acute myelogenous leukemia (AML)</atitle><jtitle>American journal of ophthalmology</jtitle><addtitle>Am J Ophthalmol</addtitle><date>2004-10-01</date><risdate>2004</risdate><volume>138</volume><issue>4</issue><spage>659</spage><epage>662</epage><pages>659-662</pages><issn>0002-9394</issn><eissn>1879-1891</eissn><coden>AJOPAA</coden><abstract>Present a case of bilateral foveal acute myelogenous leukemic tumors that responded to radiation therapy.
Case report.
A patient was diagnosed with bilateral subfoveal infiltration of known systemic acute myelogenous leukemia. He received a standard induction chemotherapy, followed by consolidation therapy for his systemic leukemia. However, despite a complete marrow response, the intraocular tumors did not regress. Therefore, he was given low dose (1950-cGy) ocular external beam radiation therapy.
One course of systemic cytarabine chemotherapy failed to control the subfoveal tumors, leaving the patient at risk for permanent vision loss. In contrast, external beam radiation therapy improved his vision from 20/60 in his right eye to 20/20 and from 20/70 in his left eye to 20/25.
Although systemic chemotherapy can be used to treat intraocular metastasis, external beam radiation may provide more prompt resolution of vision-threatening tumors.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>15488802</pmid><doi>10.1016/j.ajo.2004.04.047</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-9394 |
ispartof | American journal of ophthalmology, 2004-10, Vol.138 (4), p.659-662 |
issn | 0002-9394 1879-1891 |
language | eng |
recordid | cdi_proquest_miscellaneous_66975669 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Adult Biological and medical sciences Bone marrow Chemotherapy Diseases of the eye Fluorescein Angiography Hematologic and hematopoietic diseases Humans Leukemia Leukemia, Myeloid, Acute - physiopathology Leukemia, Myeloid, Acute - radiotherapy Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Male Medical sciences Radiation therapy Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) Recovery of Function - physiology Retinal Neoplasms - physiopathology Retinal Neoplasms - radiotherapy Tumors Visual Acuity - physiology |
title | Visual recovery after radiation therapy for bilateral subfoveal acute myelogenous leukemia (AML) |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T07%3A11%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Visual%20recovery%20after%20radiation%20therapy%20for%20bilateral%20subfoveal%20acute%20myelogenous%20leukemia%20(AML)&rft.jtitle=American%20journal%20of%20ophthalmology&rft.au=Finger,%20Paul%20T.&rft.date=2004-10-01&rft.volume=138&rft.issue=4&rft.spage=659&rft.epage=662&rft.pages=659-662&rft.issn=0002-9394&rft.eissn=1879-1891&rft.coden=AJOPAA&rft_id=info:doi/10.1016/j.ajo.2004.04.047&rft_dat=%3Cproquest_cross%3E3556265351%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1644883030&rft_id=info:pmid/15488802&rft_els_id=S0002939404004611&rfr_iscdi=true |